ArrowMark Colorado Holdings’s Xilio Therapeutics XLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-83,373
Closed -$45.9K 332
2023
Q4
$45.9K Buy
+83,373
New +$45.9K ﹤0.01% 303